Literature DB >> 27165044

A Novel TTBK2 De Novo Mutation in a Danish Family with Early-Onset Spinocerebellar Ataxia.

Suzanne Granhøj Lindquist1,2, Lisbeth Birk Møller3, Christine I Dali3, Lisbeth Marner4, Erik-Jan Kamsteeg5, Jørgen Erik Nielsen6, Lena Elisabeth Hjermind6.   

Abstract

Spinocerebellar ataxia type 11 (SCA11) is rare and has previously been described in four families worldwide. We report a Danish family with onset of symptoms in early childhood and affected family members in two generations. The proband, a Danish female born in 1968, and family members were examined. Exome sequencing was performed and a "movement disorders" gene panel consisting of approximately 200 genes was used for filtering, while Sanger sequencing was used for subsequent testing for the mutation in the family. Onset of symptoms in affected family members was in early childhood. A novel frameshift mutation (c.1205_1207delinsA) in the tau-tubulin kinase 2 encoding gene, TTBK2, was identified, which was compatible with a diagnosis of SCA11. The mutation was subsequently identified in her two affected sons but not in the unaffected parents or her unaffected brother. This report further delineates the phenotypic spectrum of the rare SCA11 disease. In contrast to previously reported cases, onset of symptoms was in early childhood and the mutation was de novo in the proband.

Entities:  

Keywords:  Cerebellum; Genetics; Neurodegeneration; Spinocerebellar ataxia

Mesh:

Substances:

Year:  2017        PMID: 27165044     DOI: 10.1007/s12311-016-0786-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  8 in total

1.  Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes.

Authors:  Kirk E Lohmueller; Thomas Sparsø; Qibin Li; Ehm Andersson; Thorfinn Korneliussen; Anders Albrechtsen; Karina Banasik; Niels Grarup; Ingileif Hallgrimsdottir; Kristoffer Kiil; Tuomas O Kilpeläinen; Nikolaj T Krarup; Tune H Pers; Gaston Sanchez; Youna Hu; Michael Degiorgio; Torben Jørgensen; Annelli Sandbæk; Torsten Lauritzen; Søren Brunak; Karsten Kristiansen; Yingrui Li; Torben Hansen; Jun Wang; Rasmus Nielsen; Oluf Pedersen
Journal:  Am J Hum Genet       Date:  2013-11-27       Impact factor: 11.025

2.  A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases.

Authors:  Kornelia Neveling; Ilse Feenstra; Christian Gilissen; Lies H Hoefsloot; Erik-Jan Kamsteeg; Arjen R Mensenkamp; Richard J T Rodenburg; Helger G Yntema; Liesbeth Spruijt; Sascha Vermeer; Tuula Rinne; Koen L van Gassen; Danielle Bodmer; Dorien Lugtenberg; Rick de Reuver; Wendy Buijsman; Ronny C Derks; Nienke Wieskamp; Bert van den Heuvel; Marjolijn J L Ligtenberg; Hannie Kremer; David A Koolen; Bart P C van de Warrenburg; Frans P M Cremers; Carlo L M Marcelis; Jan A M Smeitink; Saskia B Wortmann; Wendy A G van Zelst-Stams; Joris A Veltman; Han G Brunner; Hans Scheffer; Marcel R Nelen
Journal:  Hum Mutat       Date:  2013-10-18       Impact factor: 4.878

3.  Scale for the assessment and rating of ataxia: development of a new clinical scale.

Authors:  T Schmitz-Hübsch; S Tezenas du Montcel; L Baliko; J Berciano; S Boesch; C Depondt; P Giunti; C Globas; J Infante; J-S Kang; B Kremer; C Mariotti; B Melegh; M Pandolfo; M Rakowicz; P Ribai; R Rola; L Schöls; S Szymanski; B P van de Warrenburg; A Dürr; T Klockgether; Roberto Fancellu
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

4.  Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds.

Authors:  Peter Bauer; Giovanni Stevanin; Christian Beetz; Matthis Synofzik; Tanja Schmitz-Hübsch; Ullrich Wüllner; Eric Berthier; Elisabeth Ollagnon-Roman; Olaf Riess; Sylvie Forlani; Emeline Mundwiller; Alexandra Durr; Ludger Schöls; Alexis Brice
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-28       Impact factor: 10.154

5.  Missense exchanges in the TTBK2 gene mutated in SCA11.

Authors:  Ulf Edener; Ingo Kurth; Annechristin Meiner; Frank Hoffmann; Christian A Hübner; Veronica Bernard; Gabriele Gillessen-Kaesbach; Christine Zühlke
Journal:  J Neurol       Date:  2009-06-17       Impact factor: 4.849

6.  Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11.

Authors:  Henry Houlden; Janel Johnson; Christopher Gardner-Thorpe; Tammaryn Lashley; Dena Hernandez; Paul Worth; Andrew B Singleton; David A Hilton; Janice Holton; Tamas Revesz; Mary B Davis; Paola Giunti; Paolo Giunti; Nicholas W Wood
Journal:  Nat Genet       Date:  2007-11-25       Impact factor: 38.330

7.  Clinical and genetic analysis of spinocerebellar ataxia type 11.

Authors:  Janel Johnson; Nicholas Wood; Paola Giunti; Henry Houlden
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 8.  Tau-tubulin kinase.

Authors:  Seiko Ikezu; Tsuneya Ikezu
Journal:  Front Mol Neurosci       Date:  2014-04-28       Impact factor: 5.639

  8 in total
  5 in total

1.  First finding of familial spinal cerebellar Ataxia11 in China: clinical, imaging and genetic features.

Authors:  Yan Deng; Jie Fu; YuQin Zhong; Ming Zhang; Xueliang Qi
Journal:  Neurol Sci       Date:  2019-09-04       Impact factor: 3.307

Review 2.  Tau tubulin kinases in proteinopathy.

Authors:  Laura M Taylor; Pamela J McMillan; Brian C Kraemer; Nicole F Liachko
Journal:  FEBS J       Date:  2019-05-22       Impact factor: 5.542

3.  Phosphorylation of multiple proteins involved in ciliogenesis by Tau Tubulin kinase 2.

Authors:  Ondrej Bernatik; Petra Pejskova; David Vyslouzil; Katerina Hanakova; Zbynek Zdrahal; Lukas Cajanek
Journal:  Mol Biol Cell       Date:  2020-03-04       Impact factor: 4.138

4.  TTBK2 and primary cilia are essential for the connectivity and survival of cerebellar Purkinje neurons.

Authors:  Emily Bowie; Sarah C Goetz
Journal:  Elife       Date:  2020-01-14       Impact factor: 8.140

Review 5.  Next-generation sequencing in neuromuscular diseases.

Authors:  Stephanie Efthymiou; Andreea Manole; Henry Houlden
Journal:  Curr Opin Neurol       Date:  2016-10       Impact factor: 5.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.